Sergey Gavrilov

Prof. Sergey Gavrilov

Surgery and Vascular Surgery, Pirogov Russian National Research Medical University, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in International Journal of Women's Health
Verified
Journal Article
Open access
PDF file
SGSergey Gavrilov
Sergey Gavrilov
Objective: Vulvar varicosity is a relatively common venous disorder in women with varicose veins of the pelvis and lower extremities and in pregnant women, but there is little information in the medical literature concerning its diagnosis and management. The aim of this study was to describe our experience with 101 women with vulvar varicosities who were examined and treated at our center during 2000–2014. Patients and methods: Patients were divided into two groups: group 1 with 61 women with varicose veins of the pelvis and enlarged vulvar veins, and group 2 with 40 pregnant women (11–38 weeks of pregnancy) with vulvar varicosities. Results: In most cases, vulvar varicosities were able to be diagnosed at clinical examination. In both groups, duplex ultrasound of the veins of the pelvis and lower extremities was used to confirm the presence of varicose veins, identify any retrograde flow, accurately determine vein diameter, and to reveal any anatomical feature of the intrapelvic veins. Treatment approaches varied significantly between the two groups from purely conservative measures during pregnancy to surgical procedures on the ovarian and vulvar veins in group 1. The venoactive agent, micronized purified flavonoid fraction, was effective at reducing the symptoms of vulvar varicosities in both groups. Conclusion: A tailored approach to the diagnosis and treatment of vulvar varicosities can significantly improve the quality of care of women with this disorder.

1 November 2020 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
SGSergey Gavrilov
Sergey Gavrilov
AVAlexey V. Vasilyev
Alexey V. Vasilyev
GKGennady V. Krasavin
Gennady V. Krasavin
YMYekaterina P. Moskalenko
Yekaterina P. Moskalenko
NMNadezhda Y. Mishakina
Nadezhda Y. Mishakina

22 June 2017 in Phlebology: The Journal of Venous Disease
Verified
Journal Article
Closed access
SGSergey Gavrilov
Sergey Gavrilov
AKAv Karalkin
Av Karalkin
OTOo Turischeva
Oo Turischeva
To study the influence of compression treatment on clinical manifestations and venous hemodynamics of the pelvis in patients with pelvic congestion syndrome. A prospective study of the various options and modes of compression treatment was carried out and included 74 patients with pelvic congestion syndrome in 2008–2015. The patients were divided into three groups. The first group consisted of 48 patients with symptoms of pelvic congestion syndrome and chronic pelvic pain. They used Class II compression shorts. In the second group, there were 14 patients with pelvic congestion syndrome, vulvar varicosities without pelvic pain. They used Class II compression shorts and stockings. In the third group, 12 women with pelvic congestion syndrome and chronic pelvic pain used only the Class II compression stockings. The treatment continued for 14 days. A clinical criterion was the change of severity of chronic pelvic pain. The evaluation of the treatments has been performed using radionuclide venography and emission computed tomography with labeled in vivo red blood cells. Group 1: The compression shorts had a positive effect on the disease in 81.3% of patients. Chronic pelvic pain decreased from 6.4 ± 1.6 to 1.2 ± 0.7 points. The coefficient of pelvic congestion syndrome (Cpcs) decreased from 1.73 ± 0.32 to 1.12 ± 0.27 (p < 0.05). In 18.8% of patients, no positive effect was observed. Group 2: The results of radionuclide venographyshowed accelerating outflow of blood from the lower limbs and reduction of insufficiency of perforating veins. Mean radionuclide transit time decreased in all patients in the tendon, muscle pump parts, popliteal vein and was respectively: 23.6 ± 2.2 s, 29.6 ± 3.4 s, 32.3 ± 4.2 s and after treatment 16.4 ± 3.1 s, 22.1 ± 2.5 s, 25.7 ± 1.9 s (p < 0.05). Group 3: The use of compression stockings class II on the clinical manifestations of pelvic congestion syndrome in the patients. Cpcs also remained unchanged. Research has shown the efficiency of class II compression shorts in the treatment of patients with isolated extension of intrapelvic venous plexuses. Class II compression stockings do not have any impact on the clinical manifestations of pelvic congestion syndrome.

1 November 2021 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
SGSergey Gavrilov
Sergey Gavrilov
YMYekaterina P. Moskalenko
Yekaterina P. Moskalenko
NMNadezhda Y. Mishakina
Nadezhda Y. Mishakina
OEOksana I. Efremova
Oksana I. Efremova
VKValery M. Kulikov
Valery M. Kulikov
AGAnastasiya S. Grishenkova
Anastasiya S. Grishenkova

1 January 2021 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
SGSergey Gavrilov
Sergey Gavrilov
ASAlexander Sazhin
Alexander Sazhin
GKGennady Krasavin
Gennady Krasavin
EMEkaterina Moskalenko
Ekaterina Moskalenko
NMNadeshda Mishakina
Nadeshda Mishakina

29 March 2017 in Current Medical Research and Opinion
Verified
Journal Article
Closed access
SGSergey Gavrilov
Sergey Gavrilov
OTO. O. Turischeva
O. O. Turischeva
Introduction: This brief review describes conservative treatment methods for pelvic venous congestion. Therapy options: The authors present an analysis of the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs), ergot alkaloid derivatives, hormonal agents, venoprotective agents, and compression therapy in the treatment of pelvic congestion syndrome (PCS) as well as indications for medical therapy. Conclusion: The paucity of studies addressing this topic and the need for large multidisciplinary studies to explore the opportunities for non-surgical treatment of PCS are highlighted.